Try our Advanced Search for more refined results
April 26, 2012
Orion Corporation v. Mylan Pharmaceuticals Inc.
Case Number:
1:12-cv-00523
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
July 25, 2013
Mylan Settles With Orion Over Planned Stalevo Generic
Mylan Inc. on Thursday announced it had reached a settlement with Orion Corp. over its planned generic version of Parkinson's disease treatment Stalevo, ending a patent infringement dispute in Delaware federal court.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login